StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Connect Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$60.58M. For fiscal 2025 it was -$51.21M. The highest annual figure on record is -$23.61M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$51.21M–
FY2024Dec 31, 2024-$23.61M–
FY2023Dec 31, 2023-$47.74M–
FY2022Dec 31, 2022-$101.52M–
FY2021Dec 31, 2021-$84.32M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.92M–
Q1 FY2026Mar 31, 2026-$16.01M–
Q4 FY2025Dec 31, 2025-$11.25M–
Q3 FY2025Sep 30, 2025-$17.41M–
Q2 FY2025Jun 30, 2025-$12.59M–
Q1 FY2025Mar 31, 2025-$9.96M–
Q4 FY2024Dec 31, 2024-$2.32M–
Q3 FY2024Sep 30, 2024-$13.01M–
Q2 FY2024Jun 30, 2024-$7.70M–
Q1 FY2024Mar 31, 2024-$591.00K–

More Connect Biopharma figures

See a number that looks wrong?